Smartwatch Blood Pressure Monitoring: Which One Works?

By

·

A close-up of a smartwatch on a wrist displaying a heart rate reading, the kind of device this smartwatch blood pressure monitoring comparison covers.
Some links on our site may earn us a commission at no extra cost to you. Learn more. This article is for general informational purposes only and is not medical advice. Blood pressure affects your cardiovascular health directly. Talk to a doctor before changing how you monitor or manage it. Don’t rely on any consumer wearable in place of a validated cuff for a diagnosis.

Smartwatch blood pressure monitoring works completely differently across three devices. Only the Omron HeartGuide gives you a real reading the way a doctor’s cuff does. Apple Watch Series 11 only sends a passive notification if it detects hypertension-like patterns over time. It never shows a systolic/diastolic reading. Samsung’s Galaxy Watch does show an actual number, but it’s an uncleared “wellness feature.” That feature needs monthly recalibration against a real cuff to stay meaningful. Omron’s HeartGuide is the outlier: it’s a true inflatable cuff built into a watch band. It’s also the only one of the three that’s FDA-cleared as an actual blood pressure monitor.

A wellness feature on a gadget and a real medical reading are two different things. Even when the app shows a similar-looking number, they aren’t the same. So I’ve learned to check what a device is cleared to do before trusting what it shows.

Which smartwatch blood pressure monitoring option works best?

After years of doctor’s-office cuff checks, the Omron HeartGuide is where I’d start, because it’s cleared for a real reading, not a wellness guess. The Omron HeartGuide is the only FDA-cleared blood pressure monitor of the three, at $499. Meanwhile, the Samsung Galaxy Watch shows a real number for $299.99 but isn’t FDA-cleared. The Apple Watch Series 11 only sends a passive hypertension notification, with no number at all.

PickBest forPrice
Apple Watch Series 11Best for early-warning screening — flags a hypertension pattern passively, doesn’t show a number, no calibration hassleFrom $399
Samsung Galaxy WatchBest for a rough daily trend — shows real systolic/diastolic numbers, but needs a cuff to recalibrate every 28 days and isn’t FDA-cleared$299.99
Omron HeartGuideBest for an actual clinical-grade reading — a real oscillometric cuff on your wrist, FDA-cleared since 2019$499

Optical vs. oscillometric: what’s the real difference?

Optical sensors estimate blood pressure from light reflected off your skin. Oscillometric sensors, though, physically inflate a cuff against your wrist the same way a doctor’s cuff does. Only one device in this comparison uses that second method. The first is optical — a light-based (PPG) sensor watches how your blood vessels respond to each heartbeat. From that, it estimates pressure or flags a pattern. The second is oscillometric — an actual miniature air cuff inflates against your wrist and measures pressure mechanically. That’s the same physical principle as the cuff at your doctor’s office. Only one device in this comparison uses the second method.

Close-up of a fitness tracker display showing vital signs data on a wrist
Most wrist health sensors, including both smartwatches here, work by shining light into your skin and analyzing the reflection. That’s not the same as physically squeezing your artery like a real cuff does.

That distinction matters because the FDA regulates the two very differently. A device that displays an actual number and is marketed for managing a diagnosed condition typically needs medical-device clearance. A feature like that flags a pattern for you to discuss with a doctor. Without ever displaying a number, it can qualify for a lighter review pathway. In some cases, it needs no review at all if it’s framed purely as “wellness.” That’s exactly the fork in the road between our three devices.

Apple Watch Series 11: Notification, Not a Number

Apple’s hypertension notification feature works entirely in the background. It was introduced with Apple Watch Series 11 and watchOS 26. According to Apple’s own September 2025 announcement, the feature “uses data from the optical heart sensor to analyze how a user’s blood vessels respond to the beats of the heart.” That review happens passively over rolling 30-day periods. If the algorithm sees a consistent pattern associated with chronic high blood pressure, it sends a notification. That’s the entire output. There is no systolic or diastolic number anywhere in the experience.

The feature received FDA clearance in September 2025. It’s available on Apple Watch Series 9 and later, plus Apple Watch Ultra 2 and later, running watchOS 26. That means it isn’t exclusive to the newest Series 11 hardware, though Apple launched it alongside that model. Apple’s guidance for anyone who gets a notification is simple: log blood pressure with a separate cuff for seven days. Then share those readings with a doctor. That underscores that the watch is a screening trigger, not a diagnostic tool. Apple Watch Series 11 (GPS, 42mm) starts at $399 at retail. It’s been discounted to around $299 repeatedly through 2026, according to retailer listings.

Samsung Galaxy Watch: Not FDA-Cleared

Samsung takes the opposite approach. Its Blood Pressure Monitoring feature is built into the Samsung Health Monitor app. It displays an actual systolic and diastolic reading plus heart rate, using the watch’s optical sensors and a pulse-wave-analysis algorithm. It’s compatible with Galaxy Watch4 and later running Wear OS 4.0 or newer. Samsung began a phased US rollout of the feature on April 6, 2026, after years of it being US-restricted.

Senior adult checking blood pressure with a traditional digital arm cuff monitor at home
Galaxy Watch owners still need a real cuff like this one on hand. Samsung requires recalibrating the watch against it roughly every 28 days for the reading to stay meaningful.

The catch is regulatory, not technical. Samsung has been explicit that the feature “doesn’t require FDA clearance”, since it’s a wellness feature, not a medical device. The company’s own guidance also says not to treat it as “an alternative to a medical-grade blood pressure monitor.” On top of that, the watch needs recalibrating against a real cuff roughly every 28 days to stay accurate. Skip that, and Samsung’s own documentation says the readings drift. Galaxy Watch8 (40mm, Wi-Fi/Bluetooth) starts at $299.99 directly from Samsung. Most of that price range from Watch4 onward supports the feature.

Omron HeartGuide: FDA-Cleared Smartwatch Blood Pressure Monitoring

Omron’s HeartGuide is a fundamentally different product category wearing a smartwatch’s clothing. Instead of estimating pressure from light and an algorithm, it uses a miniature oscillometric pump built into the watch band. That pump uses the same mechanism as a standard clinical cuff, inflating against your wrist to take a real measurement. Omron received 510(k) FDA clearance for the HeartGuide on January 8, 2019. As far as we can verify, it remains the only wrist-worn device with that specific clearance for blood pressure measurement. That’s rather than a wellness estimate or a notification.

That accuracy comes with real tradeoffs. The inflation cycle takes roughly 30 seconds and feels like a scaled-down version of a normal cuff reading. That’s noticeably different from the instant, passive readings of the other two watches. It’s also the most expensive device here by a wide margin, at $499 direct from Omron Healthcare. Its smartwatch features — notifications, step tracking — are secondary to its core job as a medical device you wear.

What does each device give you, and what does it cost?

The Omron HeartGuide is the only one of the three that shows an FDA-cleared blood pressure number, at $499. The Samsung Galaxy Watch shows a number too, but isn’t FDA-cleared, at $299.99. Meanwhile, the Apple Watch Series 11 shows no number at all, starting at $399.

DeviceShows an Actual BP Number?FDA StatusOngoing EffortPrice
Apple Watch Series 11No — notification only, no systolic/diastolic displayFDA-cleared (hypertension notification, September 2025)None — passive background monitoringFrom $399 ($299 on frequent sales)
Samsung Galaxy Watch (Watch4+)Yes — full systolic/diastolic readingNot FDA-cleared — self-classified as a wellness featureRecalibrate against a real cuff every ~28 daysFrom $299.99 (Galaxy Watch8)
Omron HeartGuideYes — true oscillometric measurementFDA 510(k)-cleared (January 8, 2019)None beyond normal cuff-style use$499

Prices reflect current manufacturer and retailer listings as of publication and change frequently.

Which Smartwatch Blood Pressure Monitoring Feature Should You Trust?

If you want an early warning without buying a new device, the Apple Watch’s notification feature is the lowest-friction option. It works passively on hardware many people already own. Its entire job is to tell you when to go get a real reading elsewhere. It’s a smoke detector, not a thermometer, and that’s a legitimate, FDA-cleared use case on its own terms.

If you have already-diagnosed hypertension and want to log daily trends without a separate cuff, consider the Galaxy Watch. It’s the middle path — go in accepting that “not FDA-cleared” is a real limitation, not a technicality. Also know that skipping the 28-day recalibration undermines the entire feature. It’s a trend tool, not a diagnostic one.

If you need a number a doctor can rely on, the Omron HeartGuide is built for that job. That’s true whether you’re titrating medication, managing a diagnosed condition closely, or your doctor has specifically asked for home readings. It costs more and takes longer per reading because it’s doing something fundamentally more rigorous than the other two.

How We Compared These Blood Pressure Monitoring Smartwatches

This comparison draws on each device’s FDA clearance status and published specs. It also looks at how each device measures or estimates blood pressure. Our conclusions are built from each manufacturer’s own specifications, FDA clearance documents, and outlet reporting on each feature’s rollout. We cross-referenced all of that against each other, rather than relying on any single source. Where we cite a price or clearance date, we verified it directly against the manufacturer’s current listing. Or, we checked the relevant FDA filing. You can read more about our process on our editorial standards page. Prices are approximate, current as of publication, and change frequently — confirm the latest price with the retailer before buying.

Published August 7, 2026. Updated September 8, 2026.

Blood Pressure Monitoring Smartwatches: FAQ

Can any smartwatch measure blood pressure like a doctor’s cuff?

Not in the traditional sense, with one narrow exception. Omron’s HeartGuide uses a true inflatable oscillometric cuff built into the band and is FDA-cleared for actual blood pressure measurement. Apple Watch and Samsung Galaxy Watch both use optical sensors instead. Apple only sends a hypertension notification with no number. Samsung’s shows a number but isn’t FDA-cleared and needs monthly recalibration.

Is the Apple Watch hypertension alert a blood pressure reading?

No. Apple’s feature only sends a notification if it detects a pattern consistent with chronic hypertension over a rolling 30-day window. It never displays a systolic or diastolic number. Apple’s own guidance is to confirm any alert with a real blood pressure cuff over the following week. Then share those readings with a doctor.

Is Samsung’s Galaxy Watch blood pressure feature FDA-approved?

No. Samsung has said the feature doesn’t require FDA clearance because it’s classified as a wellness feature, not a medical device. The company explicitly advises against treating it as a substitute for a medical-grade blood pressure monitor.

Why does the Galaxy Watch need to be recalibrated with a cuff?

It estimates blood pressure from optical pulse-wave data rather than measuring it directly. Because of that, its accuracy drifts over time as your baseline vascular signals change. Samsung requires recalibrating against a traditional cuff roughly every 28 days to keep the estimate meaningful.

Is the Omron HeartGuide worth the extra cost over a smartwatch?

If you need a genuinely reliable number, yes — it’s the only device here cleared and built for that job. That’s true whether you’re managing diagnosed hypertension, adjusting medication, or tracking readings a physician will rely on. If you just want a general early-warning signal, a smartwatch’s notification feature may be enough.

Do any of these devices replace regular doctor visits?

No. All three manufacturers frame their features as screening or trend tools. Those tools are meant to prompt a conversation with a healthcare provider, not to replace clinical monitoring or diagnosis. Talk to a doctor about how to interpret any reading or notification from a consumer wearable.

Curious how other health wearables stack up? Our comparison of Abbott Lingo vs. Dexcom Stelo vs. Signos glucose monitors covers a similar accuracy-vs-convenience tradeoff for at-home health tracking, and our smart scales vs. body composition monitors comparison looks at another wrist-adjacent health metric worth double-checking before you trust it. For more wearable comparisons like this one, browse our full Wearable Tech category.